NCT00578448View on ClinicalTrials.gov

Belatacept Pharmacokinetic Trial in Renal Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2012

Conditions
Renal Transplantation
Interventions
DRUG

Belatacept

IV infusion

Trial Locations (5)

1425

Local Institution, Capital Federal

20219

Local Institution, Aguascalientes

48202

Henry Ford Hospital, Detriot

62448

Local Institution, Cuernavaca

01107

Western New England Renal & Transplant, Springfield

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY